Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05296226
Other study ID # IRB-UOL-FAHS/1085/2021
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date January 3, 2020
Est. completion date May 24, 2022

Study information

Verified date February 2022
Source University of Lahore
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Neck pain can occur from a number of conditions, most common is trigger points. Trigger points are of two point one is active and other is latent trigger point, hyperirritable spots located in a taut band of skeletal muscle. They produce pain locally and in a referred pattern and often accompany chronic musculoskeletal disorders. Acute trauma or repetitive micro trauma may lead to the development of stress on muscle fibers and the formation of trigger points Khadijeh Otadi and her colleague study in 2020, to compare immediate and short-term effects of combining dry needling patient education vs ischemic compression patient education for treating myofascial trigger points in office workers with neck pain. Both intervention groups had some positive immediate and short-term effects after 2 treatment sessions. However, Ischemic compression was more effective than Dry needling in the treatment of MTPs in office workers with neck pain. Study design: randomized control trial (RCT) Settings: study will be conducted in DHQ hospital Okara physiotherapy department. Duration of study: nine months after the approval of synopsis. Sample Size: 72 patients will be randomly divided into two equal groups of 36 each.


Description:

A trigger points is composed of numerous so-called contraction knots. An individual contraction knot appears as a segment of a muscle fiber with extremely contracted sarcomeres and an increased diameter. 2 Trigger point can occur in a number of muscles but they are most common in rhomboid and trapezius muscles. The trapezius is a large paired trapezoid-shaped surface muscle that extends longitudinally from the occipital bone to the lower thoracic vertebrae of the spine and laterally to the spine of the scapula. The trapezius has three functional parts: upper, middle and inferiorfinding typically associated with a trigger point. 5 Active trigger point is any point that causes tenderness and referral pain pattern on palpation. Almost always central trigger points are active and some satellite trigger points are also active. Active trigger points usually produce referred pain and tenderness. In contrast, latent trigger points are foci of hyperirritability in a taut band of muscle, which are clinically associated with a local twitch response, tenderness and referred pain upon manual examination A researcher assessed in 2017, the immediate neurophysiological and clinical effects of DN in patients with upper trapezius MTrPs. The results of this study showed that one session of DN targeting active MTrPs appears to reduce hyperactivity of the sympathetic nervous system and irritability of the motor endplate. DN seems effective at improving symptoms and deactivating active MTrPs. A study was conducted by Aleksandra k et al in 2018 that aimed to assess the effects of compression trigger point therapy on the stiffness of the trapezius muscle in professional basketball players. Study confirmed that a single treatment session of active myofascial trigger points with ischemic compression causes a decrease in muscle stiffness of the upper portion of the trapezius muscle. A decrease of muscle stiffness has been suggested to improve deficits in range of motion and thereby lower the risk of injuries among baseball players. The patient's total session of treatment will be 4 weeks. The date will be collected by using questionnaire Neck disability index and Numerical pain rating scale. The number of patients will be randomly allocated 72 patients and 36 patients in each group. And they will be given session of dry needling and ischemic compression in 3 alternate days in a week. Results will be noted immediate after the treatment session then again note the response 3 days after treatment session and ultimately note the response 1 month after the treatment session


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 72
Est. completion date May 24, 2022
Est. primary completion date October 10, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria: - • Age 18-40 years. - Presence of palpable taut band in muscle. - Presence of a hypersensitive tender spot in the taut band. - Pain at least 8 points on a numeric pain scale (NPS) Exclusion Criteria: - History of fibromyalgia syndrome, whiplash injury, cervical spine surgery and fracture, cervical radiculopathy. - Any systematic disease such as rheumatism, tuberculosis, cervical myelopathy, or multiple sclerosis. - Peripheral nerve entrapment, fibromyalgia, hypermobility syndrome, shoulders diseases (tendonitis, bursitis, and capsulitis).

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
dry needling and ischemic compression
dry needling is an invasive procedure where a fine Needle or acupuncture needle is inserted into the skin and muscle Ischemic compression is one of the least invasive trigger point therapies. Ischemic compression is a mechanical treatment of myofascial trigger points that consists of application of sustained pressure for a long enough time to inactivate the trigger points.

Locations

Country Name City State
Pakistan Hafiz Ijaz Bhaati Okara Punjab

Sponsors (1)

Lead Sponsor Collaborator
University of Lahore

Country where clinical trial is conducted

Pakistan, 

Outcome

Type Measure Description Time frame Safety issue
Primary NPRS The number of patients will be 36. And they will be given session in 3 alternate days in a week. Results will be noted immediate after the treatment session then again note the response 3 days after treatment session and ultimately note the response 1 month after the treatment session. The patient's total session of treatment will be 4 weeks. 4 weeks
Primary NDI The number of patients will be 36. And they will be given session in 3 alternate days in a week. Results will be noted immediate after the treatment session then again note the response 3 days after treatment session and ultimately note the response 1 month after the treatment session. The patient's total session of treatment will be 4 weeks. 4 weeks
Primary ROM The number of patients will be 36. And they will be given session in 3 alternate days in a week. Results will be noted immediate after the treatment session then again note the response 3 days after treatment session and ultimately note the response 1 month after the treatment session. The patient's total session of treatment will be 4 weeks. 4 weeks
See also
  Status Clinical Trial Phase
Completed NCT04161105 - Treatment Time-frame Guideline for Dry Needling in the Lower Limb N/A
Completed NCT05554887 - Effect of Thoracic Manipulation on Latent Trigger Point N/A
Completed NCT02609412 - Immediate Effects of Self-myofascial Release on Latent Trigger Point Sensitivity N/A
Completed NCT02393352 - Benefits of Dry Needling in Trigger Points on Autonomic Nervous System and Corporal Composition in Patients With Fibromyalgia Syndrome N/A
Completed NCT03946995 - Dry Needling Versus Graston Technique in Active Myofascial Trigger Points on Upper Trapezius N/A
Completed NCT04394741 - Effects of Dry Needling on Stiffness in Latent Trigger Points N/A
Completed NCT04179214 - Thoracic Spine Manipulation on Pressure Pain Sensitivity of Active Myofascial Trigger Points in Rhomboid Muscle N/A
Completed NCT05249660 - Instrument Assisted Soft Tissue Mobilization Versus Trigger Points Release on Upper Trapezius Trigger Points N/A
Completed NCT02374073 - Functional Massage of Teres Major Muscle N/A
Completed NCT04089228 - Kinesio Taping on Trapezius Trigger Points After Integrated Neuromuscular Inhibition Technique (INIT) N/A
Completed NCT03375229 - Dry Needling and Low-level Laser Therapy to Treat Myofascial Pain N/A
Completed NCT03500861 - Trigger Point Dry Needling for Chronic Tension-Type Headache N/A